Edition:
India

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

81.19USD
19 Sep 2017
Change (% chg)

$-1.21 (-1.47%)
Prev Close
$82.40
Open
$82.68
Day's High
$82.68
Day's Low
$81.13
Volume
1,356,147
Avg. Vol
1,435,602
52-wk High
$89.71
52-wk Low
$69.35

Chart for

About

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $111,618.30
Shares Outstanding(Mil.): 1,354.59
Dividend: 0.46
Yield (%): 2.23

Financials

BRIEF-Medtronic announces FDA approval, U.S. launch of spinal cord stimulator

* Medtronic announces FDA approval and U.S. launch of next generation spinal cord stimulator for chronic pain management Source text for Eikon: Further company coverage:

18 Sep 2017

BRIEF-New five-year gender subset data from the Medtronic engage registry presented in viva late breaking trials

* New five-year gender subset data from the medtronic engage registry presented in viva late breaking trials

14 Sep 2017

BRIEF-Medtronic plc ‍announces global launch of StealthStation ENT​

* Medtronic Plc - ‍announced global launch of StealthStation ENT​ Source text for Eikon: Further company coverage:

12 Sep 2017

BRIEF-Medtronic announces voluntary recall of diabetes infusion sets

* Medtronic announces voluntary recall of diabetes infusion sets

11 Sep 2017

UPDATE 1-Medtronic to recall some diabetes infusion sets

Sept 11 Medical device maker Medtronic Plc said on Monday it would recall certain infusion sets used with its insulin pumps by diabetes patients due to a component that could cause death in extreme cases.

11 Sep 2017

Medtronic to recall diabetes infusion sets

Sept 11 Medtronic Plc on Monday said that it would recall certain infusion sets used with all its insulin pumps due to a discontinued component.

11 Sep 2017

BRIEF-Medtronic announces Japanese regulatory approval for IN.PACT Admiral drug-coated balloon

* Medtronic announces japanese regulatory approval for the IN.PACT Admiral drug-coated balloon

08 Sep 2017

BRIEF-Medtronic launches long term clinical study program of infuse bone graft in 2 common spine procedures PLF, TLIF

* Medtronic launches long term clinical study program of infuse bone graft in two common spine procedures: PLF and TLIF

05 Sep 2017

US STOCKS-Futures flat as N. Korea concerns ease; data in focus

Aug 30 U.S. stock index futures were little changed on Wednesday as investors' jitters over North Korea's latest missile test eased and focus shifted to a clutch of economic data.

30 Aug 2017

BRIEF-Mazor Robotics says Medtronic to make $40 million third tranche investment in Mazor

* Mazor Robotics and Medtronic enter next phase of strategic partnership; Medtronic to make a $40 million third tranche investment in Mazor

30 Aug 2017

Earnings vs. Estimates